DFFN logo

DFFN Cash From Operations

Annual CFO

-$14.97 M
-$467.30 K-3.22%

December 31, 2022

Summary

Performance

1-Year Change

-3.22%

3-Year Change

-51.84%

5-Year Change

-21.38%

15-Year Change

-21.38%

DFFN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.00
DFFN annual cash flow from operations is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$14.97 M
DFFN annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
DFFN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
DFFN next annual earnings announcement has not yet been scheduled

OtherDFFNcash flowmetrics:

Annual CFI

-$12.24 M
DFFN annual cash flow from investing activities is -$12.24 million

Annual CFF

$5000.00
DFFN annual cash flow from financing activities is $5000.00

Annual FCF

-$14.97 M
DFFN annual free cash flow is -$14.97 million

Annual CAPEX

-
DFFN annual capital expenditures value is unknown

Quarterly CFO

-$2.65 M
+$2.32 M+46.74%

June 30, 2023

Summary

Performance

3-Month Change

+46.74%

1-Year Change

+33.97%

3-Year Change

+15.83%

5-Year Change

-4.17%

DFFN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$503.00 K
DFFN quarterly cash flow from operations is currently -626.04% below its historical high of $503.00 thousand

3-Year Low

-$4.97 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
DFFN previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
DFFN next earnings announcement has not yet been scheduled

OtherDFFNcash flowmetrics:

Quarterly CFI

$3.00 M
DFFN quarterly cash flow from investing activities is $3.00 million

Quarterly CFF

$0.00
DFFN quarterly cash flow from financing activities is $0.00

Quarterly FCF

-$2.65 M
DFFN quarterly free cash flow is -$2.65 million

Quarterly CAPEX

-
DFFN quarterly capital expenditures value is unknown

TTM CFO

-$13.85 M
+$1.36 M+8.95%

June 30, 2023

Summary

Performance

3-Month Change

+8.95%

1-Year Change

+6.03%

3-Year Change

-23.2%

5-Year Change

-40.45%

DFFN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$153.30 K
DFFN TTM cash flow from operations is currently -9132.09% below its historical high of $153.30 thousand

3-Year Low

-$15.21 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
DFFN previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
DFFN next earnings announcement has not yet been scheduled

OtherDFFNcash flowmetrics:

TTM CFI

$22.88 M
DFFN TTM cash flow from investing activities is $22.88 million

TTM CFF

$0.00
DFFN TTM cash flow from financing activities is $0.00

TTM FCF

-$13.85 M
DFFN TTM free cash flow is -$13.85 million

TTM CAPEX

-
DFFN TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

DFFN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.2%+34.0%+6.0%
3 y3 years-51.8%+15.8%-23.2%
5 y5 years-21.4%-4.2%-40.5%

DFFN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+3.2%at lowat high+87.8%at high+9.8%
5 y5-year+51.8%at low+8.5%+95.6%+40.5%+11.3%
alltimeall time<-9999.0%at low-626.0%+95.6%-9132.1%+11.3%

Diffusion Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2023
-
-$2.65 M(-46.7%)
-$13.85 M(-9.0%)
Mar 2023
-
-$4.97 M(+43.0%)
-$15.21 M(+1.6%)
Dec 2022
-$14.97 M(+3.2%)
-$3.47 M(+25.9%)
-$14.97 M(+3.1%)
Sep 2022
-
-$2.76 M(-31.2%)
-$14.52 M(-1.5%)
Jun 2022
-
-$4.01 M(-15.3%)
-$14.73 M(+4.8%)
Mar 2022
-
-$4.73 M(+56.3%)
-$14.06 M(-3.1%)
Dec 2021
-$14.50 M(+7.0%)
-$3.03 M(+1.8%)
-$14.50 M(-2.5%)
Sep 2021
-
-$2.97 M(-10.7%)
-$14.87 M(-3.5%)
Jun 2021
-
-$3.33 M(-35.7%)
-$15.41 M(+1.2%)
Mar 2021
-
-$5.18 M(+52.5%)
-$15.22 M(+12.3%)
Dec 2020
-$13.55 M(+37.5%)
-$3.39 M(-3.3%)
-$13.55 M(+7.6%)
Sep 2020
-
-$3.51 M(+11.7%)
-$12.60 M(+12.1%)
Jun 2020
-
-$3.14 M(-10.3%)
-$11.24 M(+5.0%)
Mar 2020
-
-$3.50 M(+43.7%)
-$10.71 M(+8.6%)
Dec 2019
-$9.86 M(-8.5%)
-$2.44 M(+13.2%)
-$9.86 M(-5.6%)
Sep 2019
-
-$2.15 M(-17.5%)
-$10.45 M(+2.3%)
Jun 2019
-
-$2.61 M(-1.8%)
-$10.21 M(+0.7%)
Mar 2019
-
-$2.66 M(-12.2%)
-$10.14 M(-5.9%)
Dec 2018
-$10.77 M(-12.6%)
-$3.03 M(+58.0%)
-$10.77 M(+7.4%)
Sep 2018
-
-$1.92 M(-24.6%)
-$10.03 M(-16.4%)
Jun 2018
-
-$2.54 M(-22.8%)
-$12.00 M(-1.7%)
Mar 2018
-
-$3.29 M(+44.1%)
-$12.21 M(-1.0%)
Dec 2017
-$12.33 M(+14.5%)
-$2.28 M(-41.3%)
-$12.33 M(+7.6%)
Sep 2017
-
-$3.89 M(+41.6%)
-$11.46 M(+21.4%)
Jun 2017
-
-$2.75 M(-19.6%)
-$9.44 M(-1.2%)
Mar 2017
-
-$3.42 M(+141.5%)
-$9.55 M(-11.3%)
Dec 2016
-$10.77 M(+107.7%)
-$1.41 M(-24.2%)
-$10.77 M(-7.3%)
Sep 2016
-
-$1.86 M(-34.8%)
-$11.62 M(+8.2%)
Jun 2016
-
-$2.86 M(-38.3%)
-$10.74 M(+21.0%)
Mar 2016
-
-$4.63 M(+104.3%)
-$8.88 M(+71.2%)
Dec 2015
-$5.19 M(-42.6%)
-$2.27 M(+130.8%)
-$5.19 M(+6.9%)
Sep 2015
-
-$981.70 K(-1.7%)
-$4.85 M(-17.1%)
Jun 2015
-
-$998.80 K(+6.4%)
-$5.85 M(-38.7%)
Mar 2015
-
-$938.80 K(-51.4%)
-$9.54 M(+5.6%)
Dec 2014
-$9.03 M
-$1.93 M(-2.5%)
-$9.03 M(+27.2%)
Sep 2014
-
-$1.98 M(-57.8%)
-$7.10 M(+30.2%)
DateAnnualQuarterlyTTM
Jun 2014
-
-$4.69 M(+983.0%)
-$5.45 M(+316.0%)
Mar 2014
-
-$432.90 K(>+9900.0%)
-$1.31 M(+10.7%)
Dec 2013
-$1.18 M(-72.5%)
-$600.00(-99.8%)
-$1.18 M(-55.8%)
Sep 2013
-
-$333.00 K(-38.9%)
-$2.68 M(-7.8%)
Jun 2013
-
-$544.80 K(+77.9%)
-$2.91 M(+5.0%)
Mar 2013
-
-$306.20 K(-79.6%)
-$2.77 M(-35.7%)
Dec 2012
-$4.31 M(-64.2%)
-$1.50 M(+167.8%)
-$4.31 M(-28.6%)
Sep 2012
-
-$559.30 K(+37.3%)
-$6.04 M(-39.2%)
Jun 2012
-
-$407.30 K(-77.9%)
-$9.93 M(-25.3%)
Mar 2012
-
-$1.85 M(-42.7%)
-$13.30 M(+10.6%)
Dec 2011
-$12.02 M(+507.0%)
-$3.22 M(-27.6%)
-$12.02 M(+30.8%)
Sep 2011
-
-$4.45 M(+17.9%)
-$9.19 M(+67.7%)
Jun 2011
-
-$3.78 M(+560.1%)
-$5.48 M(+149.5%)
Mar 2011
-
-$572.20 K(+46.3%)
-$2.20 M(+10.9%)
Dec 2010
-$1.98 M(+87.4%)
-$391.00 K(-47.3%)
-$1.98 M(+7.6%)
Sep 2010
-
-$741.90 K(+50.9%)
-$1.84 M(+32.3%)
Jun 2010
-
-$491.80 K(+38.0%)
-$1.39 M(+5.9%)
Mar 2010
-
-$356.40 K(+42.0%)
-$1.31 M(+24.2%)
Dec 2009
-$1.06 M(+108.9%)
-$250.90 K(-14.1%)
-$1.06 M(+9.8%)
Sep 2009
-
-$292.10 K(-29.4%)
-$962.50 K(+34.7%)
Jun 2009
-
-$413.90 K(+313.1%)
-$714.30 K(+40.3%)
Mar 2009
-
-$100.20 K(-35.9%)
-$509.10 K(+0.6%)
Dec 2008
-$506.00 K(<-9900.0%)
-$156.30 K(+256.0%)
-$506.00 K(-430.1%)
Sep 2008
-
-$43.90 K(-79.0%)
$153.30 K(-363.4%)
Jun 2008
-
-$208.70 K(+114.9%)
-$58.20 K(-931.4%)
Mar 2008
-
-$97.10 K(-119.3%)
$7000.00(-7100.0%)
Dec 2007
$0.00(0.0%)
$503.00 K(-296.9%)
-$100.00(-100.0%)
Sep 2007
-
-$255.40 K(+78.0%)
-$503.10 K(+103.1%)
Jun 2007
-
-$143.50 K(+37.7%)
-$247.70 K(+137.7%)
Mar 2007
-
-$104.20 K(<-9900.0%)
-$104.20 K(<-9900.0%)
Dec 2006
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00
$0.00
Dec 2005
-$75.00 K(-99.1%)
-
-
Dec 1999
-$8.35 M(+17.5%)
-
-
Dec 1998
-$7.10 M
-
-

FAQ

  • What is Diffusion Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Diffusion Pharmaceuticals?
  • What is Diffusion Pharmaceuticals annual CFO year-on-year change?
  • What is Diffusion Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Diffusion Pharmaceuticals?
  • What is Diffusion Pharmaceuticals quarterly CFO year-on-year change?
  • What is Diffusion Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Diffusion Pharmaceuticals?
  • What is Diffusion Pharmaceuticals TTM CFO year-on-year change?

What is Diffusion Pharmaceuticals annual cash flow from operations?

The current annual CFO of DFFN is -$14.97 M

What is the all time high annual CFO for Diffusion Pharmaceuticals?

Diffusion Pharmaceuticals all-time high annual cash flow from operations is $0.00

What is Diffusion Pharmaceuticals annual CFO year-on-year change?

Over the past year, DFFN annual cash flow from operations has changed by -$467.30 K (-3.22%)

What is Diffusion Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of DFFN is -$2.65 M

What is the all time high quarterly CFO for Diffusion Pharmaceuticals?

Diffusion Pharmaceuticals all-time high quarterly cash flow from operations is $503.00 K

What is Diffusion Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, DFFN quarterly cash flow from operations has changed by +$1.36 M (+33.97%)

What is Diffusion Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of DFFN is -$13.85 M

What is the all time high TTM CFO for Diffusion Pharmaceuticals?

Diffusion Pharmaceuticals all-time high TTM cash flow from operations is $153.30 K

What is Diffusion Pharmaceuticals TTM CFO year-on-year change?

Over the past year, DFFN TTM cash flow from operations has changed by +$888.80 K (+6.03%)